Albany Molecular Research, Inc. Company Profile

05:21 EDT 1st April 2015 | BioPortfolio

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For over 22 years AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in North America, Europe and Asia now provide our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.
AMRI’s services include Contract Research (Discovery), Development and Contract Manufacturing including Aseptic Fill and Finish. Since 1991, AMRI has steadily expanded and globalized its contract services platform beyond its major U.S. facilities through a combination of acquisitions and green field initiatives, which include:

  • process development and large scale manufacturing in the UK;
  • custom library synthesis, medicinal chemistry, chemical development and cGMP scale up and manufacturing in India;
  • medicinal chemistry and in vitro biology in Singapore;
  • aseptic fill and finish capabilities in Burlington, Massachusetts. 

AMRI provides a broad range of services and technologies to provide flexible and strategic support for discovery and development of pharmaceutical products and the manufacturing of API and drug product for existing and experimental new drugs, providing geographic proximity and creative budgetary solutions. 

AMRI is also investing in a small number of discovery programs with the intention to partner promising technology, a high value added service having resulted in five clinical candidates and licensing partnerships with Bristol-Myers Squibb, Genentech and Bessor Pharma.


26 Corporate Circle
New York
United States of America


Phone: (518) 512-2000
Fax: (518) 512-2020

News Articles [785 Associated News Articles listed on BioPortfolio]

INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Albany Molecular Research, Inc. (AMRI) to Contact the Firm

NEW YORK, NY--(Marketwired - November 19, 2014) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Albany Molecular Research, Inc. ("Albany" or the "Company") (NA...

Albany Molecular Research management update

Albany IVF has joined the world renowned Boston IVF fertility network and will now be known as Boston IVF – The Albany Center.

Albany, NY (PRWEB) March 17, 2015 Albany IVF has joined the world renowned Boston IVF fertility network and will now be known as Boston IVF – The Albany Center. Internationally recognized f...

Robbins Arroyo LLP: Albany Molecular Research, Inc. (AMRI) Misled Shareholders According to a Recently Filed Class Action

SAN DIEGO and ALBANY, N.Y., Nov. 14, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Albany Molecular Research, Inc. (Nasdaq:AMRI) has filed a fe...

EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Albany Molecular Research, Inc. - AMRI

NEW YORK, Nov. 12, 2014 (GLOBE NEWSWIRE) -- The Rosen Law Firm announces that it has filed a class action lawsuit on behalf of purchasers of Albany Molecular Research, Inc. common stock (Nasdaq:AMRI)...

Molecular Diagnostics Partnering Terms and Agreements : Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz

Albany, NewYork (PRWEB) October 11, 2014 The Molecular Diagnostics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter molecular dia...

AMRI CEO to Present at the 2014 Credit Suisse Healthcare Conference

ALBANY, N.Y., Oct. 29, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the...

EQUITY ALERT: Rosen Law Firm Reminds Albany Molecular Research, Inc. Investors of Important Deadline in Class Action Filed by the Firm -- AMRI

NEW YORK, Dec. 28, 2014 (GLOBE NEWSWIRE) -- Rosen Law Firm reminds purchasers of Albany Molecular Research, Inc. common stock (Nasdaq:AMRI) between August 5, 2014 and November 5, 2014 of the importan...

PubMed Articles [2623 Associated PubMed Articles listed on BioPortfolio]

Applying the community partnership approach to human biology research.

Contemporary human biology research employs a unique skillset for biocultural analysis. This skillset is highly appropriate for the study of health disparities because disparities result from the inte...

Research progress in molecular biology of pediatric myelodysplastic syndrome.

Marked differences have been found in molecular characteristics between pediatric and adult myelodysplastic syndrome (MDS) patients. The incidence of gene mutations associated with myeloid malignances...

Editorial: molecular obesity research: lessons learned?

Research Status of Molecular Targeted Therapy in Thymic Epithelial Tumors.

In recent years, as the study of molecular mechanism and signal transduction pathways of tumors, molecular target therapy in many solid tumors has made great progress. At present, more and more studie...

Research advances on TCM anti-tumor effects and the molecular mechanisms.

With unceasingly deep researches on tumor cytology and molecular biology in recent years, it has been recognized that tumor is not only the outcome of occurrence and progress of cell proliferative dis...

Clinical Trials [1146 Associated Clinical Trials listed on BioPortfolio]

Acute Technical Outcomes of the Talent Abdominal Aortic Aneurysm (AAA) Stent-Graft Versus Cook Zenith Stent-Graft

The purpose of this study is to compare acute technical outcomes of the Talent AAA Stent Graft system versus Cook Zenith Endograft at two high volume institutions, Albany Medical Center an...

Biopsies of Cancer Patients for Tumor Molecular Characterization

In this research study, we are looking at performing a repeat biopsy of patients' tumors, even though they have already been diagnosed with cancer. The tumor tissue obtained from the biop...

Genetic Analysis of Liver Cancer

Liver cancer is a leading cause of cancer deaths worldwide. While the molecular pathogenesis of liver cancer has been extensively studied, less is known about how the molecular biology of ...

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

RATIONALE: Using samples of blood, urine, sputum, and tissue from patients at high risk of cancer for laboratory studies may help doctors learn more about changes that may occur in DNA and...

Validation of a Molecular Prognostic Test for Eye Melanoma

Up to half of patients with ocular melanoma (also called iris, choroidal or uveal melanoma) develop metastasis. We have found that certain molecular features of the eye tumor can be detect...

Companies [1788 Associated Companies listed on BioPortfolio]

Albany Molecular Research Incorporated

Founded in 1991, Albany Molecular Research, Inc. is a chemistry company with a core nucleus of accomplished scientists who have extensive experience within the pharmaceutical industry. Albany Molecula...

Albany Molecular Research, Inc. (AMRI)

Albany Molecular Research, Inc.

Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development, and manufacturing services. For o...

Albany College of Pharmacy and Health Sciences

Founded in 1881, Albany College of Pharmacy and Health Sciences is a private, independent institution committed to the advancement of health. The College has academic programs and research activities ...


Founded in 1991, Albany Molecular Research, Inc. provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and...

More Information about "Albany Molecular Research, Inc." on BioPortfolio

We have published hundreds of Albany Molecular Research, Inc. news stories on BioPortfolio along with dozens of Albany Molecular Research, Inc. Clinical Trials and PubMed Articles about Albany Molecular Research, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Albany Molecular Research, Inc. Companies in our database. You can also find out about relevant Albany Molecular Research, Inc. Drugs and Medications on this site too.

Search BioPortfolio:

Relevant Topic

Latest News Clinical Trials Research Drugs Reports Corporate
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks

Searches Linking to this Company Record